Buy Zydus Lifesciences., target price Rs 426: Angel One

Promoters held 74.98 per cent stake in the company as of 30-Sep-2022, while FIIs owned 2.86 per cent, DIIs 12.85 per cent.

Agencies
Zydus Lifesciences, incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42001.41 Crore) operating in Pharmaceuticals sector.
Angel One has buy call on Zydus Lifesciences with a target price of Rs 426. The current market price of Zydus Lifesciences is Rs 417.6. Time period given by analyst is Intra Day when Zydus Lifesciences price can reach defined target. Angel One recommended to keep stop loss at Rs 408.8.

Zydus Lifesciences, incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42001.41 Crore) operating in Pharmaceuticals sector.

Zydus Lifesciences key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2022.


Financials
For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 4179.10 Crore, up .98 % from last quarter Total Income of Rs 4138.60 Crore and up 8.88 % from last year same quarter Total Income of Rs 3838.10 Crore. Company has reported net profit after tax of Rs 511.30 Crore in latest quarter.

The company’s top management includes Mr.Pankaj R Patel, Dr.Sharvil P Patel, Mr.Ganesh N Nayak, Mr.Bhadresh K Shah, Mr.Mukesh M Patel, Mr.Nitin R Desai, Ms.Dharmishtaben N Raval, Ms.Apurva S Diwanji. Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-09-2022, the company has a total of 101 Crore shares outstanding.

ADVERTISEMENT
Promoter/FII Holdings
Promoters held 74.98 per cent stake in the company as of 30-Sep-2022, while FIIs owned 2.86 per cent, DIIs 12.85 per cent.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Zydus Lifesciences., target price Rs 426: Angel One
Text Size:AAA
Success
This article has been saved

*

+